Femarelle Recharge
Natural health product licensed in Canada
If this product were sold in France
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycine max Source : Glycine max - Graine Extract : Matériel brut sec Extraction ratio : 2.632:1 Dry plant equivalent : 847.36 mg | 322 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxal | 1 mg | Not calculated |
| Glycine max Source : Glycine max - Graine Extraction ratio : 3.03:1 Dry plant equivalent : 975.5 mg | Not specified | Not calculated |
Non-medicinal ingredients
Graine de lin, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in normal growth and development. A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps in energy metabolism/(and) tissue formation. Helps to form red blood cells. Helps to maintain/support the body¿s ability to metabolize nutrients. Helps to prevent vitamin B6 deficiency. Maintains/supports good health. Multi-vitamin supplement. Vitamin supplement. Helps relieve symptoms associated with menopause and thereby improves quality of life. Helps relieve symptoms associated with menopause such as headaches, insomnia, interrupted sleep pattern, painful intercourse and vaginal dryness. Helps relieve menopausal symptoms (e.g., hot flushes, sleep disturbances). DT56a is Clinically shown to help reduce hot flashes/night sweats. Helps reduce intensity and frequency of menopausal symptoms such as hot flashes and/or night sweats; Helps decrease intensity and number of hot flashes; Helps decrease intensity and number of hot flashes in 4 weeks. Source of vitamin(s), a factor/factors in the maintenance of good health. Source of vitamin(s), a factor/factors in normal growth and development. Source of vitamins) to support biological functions which play a key role in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- Renu Life Sciences Inc.
- NPN or DIN-HM
- 80125188
- Status
- Active licence
- Licence date
- 23 June 2023
- Revision date
- 2 March 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80125188
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Glycine max
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Femarelle Recharge”, https://compoatlas.com/en/supplements/canada/80125188-femarelle-recharge, updated 2 March 2025.